Exacerbation Reduction in Severe Eosinophilic Asthma Based on Eosinophil Thresholds

被引:0
|
作者
Yancey, Steven W. [1 ]
Mayer, Bhabita
Gunsoy, Necdet
Keene, Oliver N.
Bleecker, Eugene G. [2 ]
Brightling, Christopher [3 ]
Pavord, Ian [4 ]
机构
[1] GlaxoSmithKline, Resp Med Franchise, Res Triangle Pk, NC USA
[2] Wake Forest Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC USA
[3] Univ Hosp Leicester NHS Trust, Inst Lung Hlth, Leicester, Leics, England
[4] Univ Oxford, Resp Med, Oxford, England
关键词
D O I
10.1016/j.jaci.2015.12.1120
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
677
引用
收藏
页码:AB208 / AB208
页数:1
相关论文
共 50 条
  • [21] Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
    Sakai, Chio
    Matsuyama, Masashi
    Nakajima, Masayuki
    Matsumura, Sosuke
    Nonaka, Mizu
    Arai, Naoki
    Kuramoto, Kenya
    Yoshida, Kazufumi
    Morishima, Yuko
    Muratani, Masafumi
    Hizawa, Nobuyuki
    ALLERGOLOGY INTERNATIONAL, 2024, 73 (03) : 473 - 476
  • [22] Efficacy of Reslizumab Treatment in Exacerbation-Prone Patients with Severe Eosinophilic Asthma
    Wechsler, Michael E.
    Hickey, Lisa
    Garin, Margaret
    Chauhan, Anoop
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (10): : 3434 - +
  • [23] A weight-based exacerbation dose-response analysis of mepolizumab in severe asthma with eosinophilic phenotype
    Pouliquen, Isabelle
    Austin, Daren
    Gunsoy, Necdet
    Yancey, Steven
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis
    Tanaka, Shunya
    Tsuji, Taisuke
    Shiotsu, Shinsuke
    Yuba, Tatsuya
    Hiraoka, Noriya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [25] Exacerbation reduction data with benralizumab in subgroups of patients with severe eosinophilic asthma (SEA) from Central Europe and Baltics (BREEZE)
    Malakauskas, Kestutis
    Staevska, Maria
    Csoma, Zsuzsanna
    Pauk, Norbert
    Iras, Bela
    Baukiene, Jurate
    Mihaltan, Florin
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [27] Severe Asthma Exacerbation
    Khalsi, F.
    Aissa, M. Y.
    Trabelsi, I. T.
    Ben Romdhane, M.
    Belhadj, I.
    Brini, I.
    Hamouda, S.
    Boussetta, K.
    PEDIATRIC PULMONOLOGY, 2021, 56 : S100 - S100
  • [28] Activation of blood eosinophil subtypes proliferative properties by eosinophilopoetins in severe nonallergic eosinophilic asthma
    Palacionyte, J.
    Rimkunas, A.
    Jurkeviciute, E.
    Januskevicius, A.
    Malakauskas, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [29] GREATER EFFICACY OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA WITH HIGH BASELINE BLOOD EOSINOPHIL COUNTS
    Silver, J.
    Llanos, J.
    Mayer, B.
    Prazma, C.
    Albers, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S37 - S38
  • [30] Blood eosinophil subtype distribution following treatment with mepolizumab in patients with severe eosinophilic asthma
    Rimkunas, Airidas
    Januskevicius, Andrius
    Vasyle, Egle
    Palacionyte, Jolita
    Jermalaviciene, Inesa
    Miliauskas, Skaidrius
    Malakauskas, Kestutis
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64